These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20070837)

  • 1. Tumor necrosis factor-alpha-converting enzyme as a potential mediator of the influence of smoking on the response to treatment with narrowband ultraviolet B in psoriasis patients.
    Serwin AB; Sokolowska M; Chodynicka B
    Photodermatol Photoimmunol Photomed; 2010 Feb; 26(1):36-40. PubMed ID: 20070837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour necrosis factor alpha (TNF-alpha)-converting enzyme (TACE) and soluble TNF-alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
    Serwin AB; Sokolowska M; Chodynicka B
    Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):130-4. PubMed ID: 17598866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour necrosis factor (TNF-alpha) alpha converting enzyme and soluble TNF-alpha receptor type 1 in psoriasis patients in relation to the chronic alcohol consumption.
    Serwin AB; Sokolowska M; Dylejko E; Chodynicka B
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):712-7. PubMed ID: 18312327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble tumor necrosis factor alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
    Serwin AB; Sokolowska M; Chodynicka B
    Photodermatol Photoimmunol Photomed; 2005 Aug; 21(4):210-1. PubMed ID: 15998370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble tumour necrosis factor-alpha receptor type 1 as a biomarker of response to phototherapy in patients with psoriasis.
    Serwin AB; Chodynicka B
    Biomarkers; 2007; 12(6):599-607. PubMed ID: 17852084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B.
    Serwin AB; Wasowicz W; Chodynicka B
    Nutrition; 2006 Sep; 22(9):860-4. PubMed ID: 16829029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble tumor necrosis factor-alpha receptor type 1 during selenium supplementation in psoriasis patients.
    Serwin AB; Mysliwiec H; Hukalowicz K; Porebski P; Borawska M; Chodynicka B
    Nutrition; 2003 Oct; 19(10):847-50. PubMed ID: 14559319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Soluble tumor-necrosis-factor-alpha receptor type-1 as a marker of activity of psoriasis vulgaris and effects of its treatment].
    Serwin AB; Sokołowska M; Chodynicka B
    Przegl Lek; 2005; 62(2):95-7. PubMed ID: 16095152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients.
    Park KK; Wu JJ; Koo J
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):899-906. PubMed ID: 22702846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure.
    Satoh M; Iwasaka J; Nakamura M; Akatsu T; Shimoda Y; Hiramori K
    Eur J Heart Fail; 2004 Dec; 6(7):869-75. PubMed ID: 15556048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
    Calzavara-Pinton PG; Sala R; Arisi M; Rossi MT; Venturini M; Ortel B
    Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of narrowband ultraviolet B phototherapy on serum tumour necrosis factor-like weak inducer of apoptosis (TWEAK) in patients with psoriasis.
    Myśliwiec H; Kiluk P; Myśliwiec P; Żelazowska-Rutkowska B; Baran A; Flisiak I
    Clin Exp Dermatol; 2017 Oct; 42(7):786-790. PubMed ID: 28748592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis.
    Romaní J; Caixàs A; Carrascosa JM; Ribera M; Rigla M; Luelmo J
    Br J Dermatol; 2012 Jun; 166(6):1237-44. PubMed ID: 22309899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.
    Gambichler T; Tigges C; Scola N; Weber J; Skrygan M; Bechara FG; Altmeyer P; Kreuter A
    Br J Dermatol; 2011 Jun; 164(6):1383-6. PubMed ID: 21466532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.
    Canault M; Leroyer AS; Peiretti F; Lesèche G; Tedgui A; Bonardo B; Alessi MC; Boulanger CM; Nalbone G
    Am J Pathol; 2007 Nov; 171(5):1713-23. PubMed ID: 17872973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in tissue plasmin: a new mechanism of action of narrowband ultraviolet B in psoriasis.
    Metwally D; Sayed K; Abdel Hay R; Rashed L
    Clin Exp Dermatol; 2015 Jun; 40(4):416-20. PubMed ID: 25557337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrowband UVB treatment increases serum 25-hydroxyvitamin D levels in patients with chronic plaque psoriasis.
    Saleky S; Bulur I; Saraçoğlu ZN
    Cutis; 2017 Jun; 99(6):431-435. PubMed ID: 28686753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital ultraviolet therapy: a novel therapeutic approach for the targeted treatment of psoriasis vulgaris.
    Werfel T; Holiangu F; Niemann KH; Schmerling O; Lüllau F; Zedler A; Sträter HD; Niebuhr M
    Br J Dermatol; 2015 Mar; 172(3):746-53. PubMed ID: 25307476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase activity is higher in psoriasis patients and is down-regulated by narrowband ultraviolet B treatment.
    Magina S; Moura E; Serrão MP; Moura D; Vieira-Coelho MA
    Eur J Dermatol; 2013; 23(1):49-52. PubMed ID: 23399536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.